The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Light from the outside world is focused onto a structure at the back of the eye called the retina. The central part of the retina - known as the macula - is crucial for vision. In some individuals the ...

November marks Diabetic Eye Disease Awareness Month, highlighting the silent vision risks of diabetes and the importance of ...

In a major step towards using artificial intelligence for preventive eye care, All India Institute of Medical Sciences, in ...

The All India Institute of Medical Sciences (AIIMS) has developed MadhuNETrAI, an AI-based mobile application designed to ...

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...

PYC Therapeutics (ASX:PYC) has announced encouraging progress with its investigational drug VP-001, designed to treat Retinitis Pigmentosa type 11 (RP11), a severe genetic eye disorder. The company ...

University of Batangas and Immaculada Concepcion College flaunted their might once again and advanced to the finals for the ...